Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Kiyoyasu Kazumori"'
Publikováno v:
Journal of Diabetes Investigation, Vol 15, Iss 8, Pp 1057-1067 (2024)
Abstract Aims/Introduction Despite the emergence of new drugs with novel mechanisms of action, treatment options for older people and those with chronic kidney disease are still limited. Materials and Methods Using a medical database compiled from Di
Externí odkaz:
https://doaj.org/article/c88f0d4bbbbe47ff8745d140fcb69d46
Publikováno v:
Journal of Diabetes Investigation, Vol 14, Iss 1, Pp 81-91 (2023)
Abstract Aims/Introduction Clinical inertia, defined as a failure of healthcare providers to initiate or intensify treatment when indicated, is one of the challenges in achieving glycemic targets in type 2 diabetes patients. Materials and Methods Usi
Externí odkaz:
https://doaj.org/article/5c04d59620e34f2eb38a702daa68d663
Publikováno v:
Journal of Diabetes Investigation. 14:81-91
Clinical inertia, defined as a failure of healthcare providers to initiate or intensify treatment when indicated, is one of the challenges in achieving glycemic targets in type 2 diabetes patients.Using a Japanese medical database compiled from Diagn
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::21e25ae4a57d435444579fb6b1d98a80
https://doi.org/10.1111/jdi.13923
https://doi.org/10.1111/jdi.13923
Publikováno v:
Diabetes Therapy
Introduction Patients with type 2 diabetes (T2D) in Japan are prescribed a lower dose of metformin that their counterparts in Western countries due to concerns for the risk of lactic acidosis incidence. Here we report our study on the association bet
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::66de7ff5a6e55d467b62b6907e209b1d
http://europepmc.org/articles/PMC7994465
http://europepmc.org/articles/PMC7994465
Publikováno v:
Diabetes Therapy
Introduction Metformin has dose-dependent hypoglycemic effects on patients with type 2 diabetes (T2D). In Japan, metformin has been prescribed at lower doses than in Western countries. We analyzed the effect of increasing the metformin dose on glycem
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::af7f165ba42dec3e2a9971b6ed12dad6
https://doi.org/10.1007/s13300-021-01017-x
https://doi.org/10.1007/s13300-021-01017-x
Publikováno v:
Journal of Gastroenterology and Hepatology. 36:1529-1537
Background and aim The impact of chronic constipation on health-related quality of life (HRQoL), work productivity, and healthcare resource use in Japan is not well understood. This study aimed to evaluate and compare the humanistic burden of respond
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dbee37197098327c35d5ea9480f06ead
https://doi.org/10.1111/jgh.15295
https://doi.org/10.1111/jgh.15295
Publikováno v:
Alimentary Pharmacology & Therapeutics
Summary Background Agonists of 5‐hydroxytryptamine 4 receptor are potential agents for irritable bowel syndrome with predominant constipation (IBS‐C). However, only tegaserod has been approved for a very limited population in the US. Aim To evalu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2d17ba0883f2796f1430f481859630a2
http://europepmc.org/articles/PMC7383621
http://europepmc.org/articles/PMC7383621
Autor:
Tatsuto, Hamatani, Shin, Fukudo, Yosuke, Nakada, Hiroshi, Inada, Kiyoyasu, Kazumori, Hiroto, Miwa
Publikováno v:
Alimentary pharmacologytherapeuticsREFERENCES. 52(7)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::c4dfa51db24bf254e6a9e7fb0639c36b
https://pubmed.ncbi.nlm.nih.gov/33016542
https://pubmed.ncbi.nlm.nih.gov/33016542
Publikováno v:
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association. 19(3)
Treatment options for irritable bowel syndrome with constipation (IBS-C) are limited-new prokinetic drugs are needed. We evaluated the efficacy and safety of minesapride (DSP-6952), a partial agonist with high affinity for 5-HT4 receptors, in patient
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e46d79959669edab6c1d0976790da6ef
https://pubmed.ncbi.nlm.nih.gov/32184185
https://pubmed.ncbi.nlm.nih.gov/32184185
Publikováno v:
Alimentary Pharmacology & Therapeutics. 52:715-716
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::43bfd9ad2c9fa29aad7351eb38389ddb
https://doi.org/10.1111/apt.15972
https://doi.org/10.1111/apt.15972